Records containing: Secondary Hyperparathyroidism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-02-10A Multi-center, Randomized, Double-blind, Parallel Grouping, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Paricalcitol Soft Capsules in the Treatment of Secondary Hyperparathyroidism in Subjects With Stage 3 and Stage 4 Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2021-10-12Comparison of Medical Therapy (Oral Cinacalcet) Versus Surgical Therapy (Total Parathyroidectomy) on Vascular/Valvular Calcification in Chronic Peritoneal Dialysis Patients With Secondary Hyperparathyroidism - A Pilot Randomized Study
-
CLINICAL_TRIALS study record update · 2021-07-13Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2021-04-30A Multicenter, Multiple-dose, Active-controlled, Double-blind, Double-dummy Study to Compare the Therapeutic Efficacy and Safety of Oral Doses of Cinacalcet Hydrochloride With Intravenous Doses of Etelcalcetide (AMG 416) in Asian Hemodialysis Subjects With Secondary Hyperparathyroidism
-
CLINICAL_TRIALS study record update · 2020-07-23USEFULNESS OF IOPTH AS A PREDICTOR FOR SUCCESSFUL PARATHYROIDECTOMY IN SECONDARY HYPERPARATHYROIDISM: A COHORT STUDY
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-06-25Intact Versus Biointact Assays for Longitudinal Assessment of Parathyroid Hormone - The Longitudinal PTH Study
-
CLINICAL_TRIALS study record update · 2020-06-09Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-03-09Phase 3 Study of SK-1403 ; Double-blinded Parallel Group in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
-
CLINICAL_TRIALS study record update · 2020-03-09SK-1403 Long-term Treatment Study - Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis -
-
CLINICAL_TRIALS study record update · 2020-02-10A Phase 1, Multiple Dose, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pharmacokinetics, Safety and Tolerability of AMG 416 Administered Intravenously to Chinese Subjects With Chronic Kidney Disease on Hemodialysis
-
CLINICAL_TRIALS study record update · 2019-09-30An Open-label, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Oral CTAP101 (Calcifediol) Extended-release Capsules in Japanese and Non-Japanese Healthy Subjects
-
CLINICAL_TRIALS study record update · 2019-03-15Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism
-
CLINICAL_TRIALS study record update · 2018-12-20Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
-
CLINICAL_TRIALS study record update · 2018-07-10A Randomized, Double-blind, Parallel-group, Dose-finding Study of KHK7580 for Secondary Hyperparathyroidism Patients Receiving Hemodialysis
-
CLINICAL_TRIALS study record update · 2018-01-23A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2017-10-26The Effect of Thiazide and Loop Diuretic on Mineral and Bone Disorder in Chronic Kidney Disease Patients
-
CLINICAL_TRIALS study record update · 2017-08-16A Phase 2A, Open-label, Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
-
CLINICAL_TRIALS study record update · 2017-07-05Phase 3 Study of KHK7580 (A Long-term Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)
-
CLINICAL_TRIALS study record update · 2017-07-05Phase 3 Study of KHK7580 (A Clinical Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Peritoneal Dialysis)
-
CLINICAL_TRIALS study record update · 2017-06-21the Study on Difference Prognostic for Low Parathyroid Hormone Levels and Severe Secondary Hyperparathyroidism in Hemodialysis Patients
-
CLINICAL_TRIALS study record update · 2017-05-02Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy
-
CLINICAL_TRIALS study record update · 2017-04-13A Multicenter Open-label Extension Study to Assess the Long-term Safety and Efficacy of KAI-4169 (Also Known as AMG 416) in the Treatment of Chronic Kidney Disease-Mineral and Bone Disorder in Patients With Secondary Hyperparathyroidism
-
CLINICAL_TRIALS study record update · 2017-04-13A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
-
CLINICAL_TRIALS study record update · 2017-04-11A Single-arm, Open-label, Multicenter, Dose Titration Study of KAI-4169 to Treat Secondary Hyperparathyroidism in Hemodialysis Subjects With Chronic Kidney Disease-Mineral and Bone Disorder
-
CLINICAL_TRIALS study record update · 2017-03-31FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease